Open Orphan's Venn secures contract renewal deal
Specialist pharmaceutical company Open Orphan said its subsidiary Venn Life Sciences has agreed a contract renewal deal with a major global pharmaceutical client worth £1.5m over two years.
Business
• 15 Nov 21
